297 related articles for article (PubMed ID: 19483274)
1. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
Shimizu Y; Fukumoto S
Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
[TBL] [Abstract][Full Text] [Related]
3. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
Fukumoto S
Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
[TBL] [Abstract][Full Text] [Related]
4. [FGF23-related hypophosphatemic rickets/osteomalacia].
Ito N; Fukumoto S
Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
[TBL] [Abstract][Full Text] [Related]
5. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
Endo I
Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
[TBL] [Abstract][Full Text] [Related]
6. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
[TBL] [Abstract][Full Text] [Related]
7. FGF23 and Bone and Mineral Metabolism.
Fukumoto S
Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
[TBL] [Abstract][Full Text] [Related]
8. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
Fukumoto S
Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
[TBL] [Abstract][Full Text] [Related]
9. Advances in understanding of phosphate homeostasis and related disorders.
Michigami T
Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
[TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
Fukumoto S
Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
[TBL] [Abstract][Full Text] [Related]
11. The role of bone in phosphate metabolism.
Fukumoto S
Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
[TBL] [Abstract][Full Text] [Related]
12. Bone-kidney axis in systemic phosphate turnover.
Razzaque MS
Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
[TBL] [Abstract][Full Text] [Related]
13. [FGF23 and skeletal metabolism].
Michigami T
Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
[TBL] [Abstract][Full Text] [Related]
14. [Significance of FGF23 measurement].
Fukumoto S
Clin Calcium; 2012 Oct; 22(10):1525-9. PubMed ID: 23023632
[TBL] [Abstract][Full Text] [Related]
15. [Hormones and osteoporosis update. FGF23/Klotho and bone metabolism].
Fukumoto S
Clin Calcium; 2009 Jul; 19(7):945-50. PubMed ID: 19567989
[TBL] [Abstract][Full Text] [Related]
16. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
Fukumoto S
Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
[TBL] [Abstract][Full Text] [Related]
17. [Fibroblast growth factor 23--a phosphate regulating hormone].
Beck-Nielsen SS; Pedersen SM; Kassem M; Rasmussen LM
Ugeskr Laeger; 2010 May; 172(20):1521-7. PubMed ID: 20483099
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.
Fukumoto S; Shimizu Y
J Bone Miner Metab; 2011 Sep; 29(5):507-14. PubMed ID: 21822586
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 and its receptors.
Yu X; White KE
Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
[TBL] [Abstract][Full Text] [Related]
20. Actions and mode of actions of FGF19 subfamily members.
Fukumoto S
Endocr J; 2008 Mar; 55(1):23-31. PubMed ID: 17878606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]